This content is in French.
Gut microbiome and neurodegeneration: a new therapeutic lever
13 février 2026
By Elodie Vaz | Published on February 12, 2026 | 3 min read
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) rank among the most severe and least understood neurodegenerative diseases. FTD preferentially affects the frontal and temporal lobes, causing major changes in behavior, personality, and language. ALS is characterized by progressive degeneration of motor neurons, leading to irreversible muscle weakness that advances to paralysis.
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) rank among the most severe and least understood neurodegenerative diseases. FTD preferentially affects the frontal and temporal lobes, causing major changes in behavior, personality, and language. ALS is characterized by progressive degeneration of motor neurons, leading to irreversible muscle weakness that advances to paralysis.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
C9orf72 in myeloid cells prevents an inflammatory response to microbial glycogen
View the source
